Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENOXAPARIN Cause Product dose omission issue? 54 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 54 reports of Product dose omission issue have been filed in association with ENOXAPARIN (Enoxaparin Sodium). This represents 0.2% of all adverse event reports for ENOXAPARIN.

54
Reports of Product dose omission issue with ENOXAPARIN
0.2%
of all ENOXAPARIN reports
3
Deaths
12
Hospitalizations

How Dangerous Is Product dose omission issue From ENOXAPARIN?

Of the 54 reports, 3 (5.6%) resulted in death, 12 (22.2%) required hospitalization, and 1 (1.9%) were considered life-threatening.

Is Product dose omission issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENOXAPARIN. However, 54 reports have been filed with the FAERS database.

What Other Side Effects Does ENOXAPARIN Cause?

Off label use (1,707) Exposure during pregnancy (1,215) Haemorrhage (1,059) Foetal exposure during pregnancy (918) Anaemia (914) Thrombocytopenia (834) Dyspnoea (822) Maternal exposure during pregnancy (818) Drug ineffective (769) Nausea (708)

What Other Drugs Cause Product dose omission issue?

DUPILUMAB (18,189) USTEKINUMAB (9,405) GUSELKUMAB (9,267) LENALIDOMIDE (8,145) MEPOLIZUMAB (5,873) TOFACITINIB (5,646) VOXELOTOR (5,122) BELIMUMAB (4,671) SECUKINUMAB (4,572) APREMILAST (4,460)

Which ENOXAPARIN Alternatives Have Lower Product dose omission issue Risk?

ENOXAPARIN vs ENOXAPARIN - WINTHROP ENOXAPARIN vs ENSIFENTRINE ENOXAPARIN vs ENTACAPONE ENOXAPARIN vs ENTECAVIR ENOXAPARIN vs ENTINOSTAT

Related Pages

ENOXAPARIN Full Profile All Product dose omission issue Reports All Drugs Causing Product dose omission issue ENOXAPARIN Demographics